Showing Product Results 1601 - 1800 of about 21923  
       See Products by First Letter      ABCDEFGHIJKLMNOPQRSTUVWXYZOtherAll       

anti-CD19 CAR-T cell therapy / Tianjin Mycure Medical  (0 Trials)

anti-CD19 CAR-T cell therapy / Zhongyuan Union Cell & Gene  (0 Trials)

anti-CD19 CAR-T cell therapy / Wuhan Sian Medical Tech  (4 Trials)

anti-CD19 CAR-T therapy / Wuhan Bio–Raid  (0 Trials)

anti-CD19 iCAR NK cells / Allife Medical Science and Technology  (1 Trials)

anti-CD19 Thiomab / Heidelberg Pharma  (0 Trials)

anti-CD19 UCAR-T cells / Gracell  (1 Trials)

anti-CD19-CAR / Kecellitics Biotech  (1 Trials)

Anti-CD19-CAR / Beijing Doing Biomedical  (1 Trials)

anti-CD19-CAR γδT / Beijing Doing Biomedical  (1 Trials)

anti-CD19-CD137 CAR-T therapy / Sinobioway  (0 Trials)

anti-CD19/22 CART cell therapy / Cellular Biomedicine  (0 Trials)

anti-CD19/BCMA CAR-T cells / Hrain Biotech  (2 Trials)

anti-CD19/CD22 CAR-T cells / Hrain Biotech  (1 Trials)

anti-CD22 ADC / BMS  (0 Trials)

Anti-CD22 CAR NK Cells / Allife Medical Science and Technology  (1 Trials)

anti-CD22 CAR-T cell therapy / Shanghai Yake Biotech  (0 Trials)

Anti-CD22 CAR-T Cells / Beijing Boren Hospital  (1 Trials)

anti-CD22 CAR-T therapy / Wuhan Bio–Raid  (1 Trials)

anti-CD22-CAR / Kecellitics Biotech  (1 Trials)

anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells / National Cancer Institute  (0 Trials)

anti-CD3+glycolipid / Harvard Medical School, Hadassah Medical Organization  (0 Trials)

anti-CD3/anti-CD7 ricin A immunotoxin / Novasep  (0 Trials)

anti-CD30 CAR T cells / Wuhan Bio–Raid  (1 Trials)

anti-CD33 CAR-NK cells / PersonGen Biomedicine  (0 Trials)

anti-CD4 802-2 / Synthetic Biologics  (0 Trials)

anti-CD47 antibody therapeutic / Sartorius  (0 Trials)

anti-CD47 monoclonal antibody / Biocad  (0 Trials)

anti-CD7 CAR-pNK cells / PersonGen Biomedicine  (1 Trials)

anti-CD7 CAR-T cell therapy / Shanghai Yake Biotech  (1 Trials)

anti-CD7 CAR-T cells / PersonGen Biomedicine  (5 Trials)

anti-CD86 X mono-IL-10 SCORPION / Emergent Biosolutions  (0 Trials)

anti-CD96 antibody / Samyang Group  (0 Trials)

Anti-CEA-CAR T / Southwest Hospital  (1 Trials)

anti-Claudin 18.2 CAR-T cell therapy / First Affiliated Hospital Xi'an Jiaotong University, Legend Biotech  (0 Trials)

anti-coronavirus antibodies / A.O. Ospedale Papa Giovanni XXIII  (1 Trials)

anti-COVID-19 mAb / Halberd  (0 Trials)

anti-COVID-19 peptide / Nuritas  (0 Trials)

anti-COVID-19 Spike protein monoclonal antibody / Halberd, Arizona State University  (0 Trials)

Anti-CTLA4 AbEnAds antibody / PsiOxus  (0 Trials)

Anti-CTLA4 antibody / Premier Biomedical  (0 Trials)

anti-CTLA4 antibody / Abzena  (0 Trials)

anti-CTLA4 monoclonal antibody / Aida Pharma  (0 Trials)

anti-CTLA4 scFv / Anaeropharma Science  (0 Trials)

anti-DLL3 CAR T cell therapy / Allogene Therap  (0 Trials)

anti-DLL4 antibody / Exelixis, Roche  (0 Trials)

anti-EGFR CAR-T / CARsgen  (0 Trials)

Anti-EphA2 CAR-T therapy / Avalon GloboCare  (1 Trials)

anti-etbr adc (DEDN6526A) / Roche  (0 Trials)

anti-FGFR-3 HuCAL antibody / MorphoSys  (0 Trials)

anti-flagellin monoclonal antibodies (INO-763) / Rocket Pharma  (0 Trials)

anti-flagellin monoclonal antibody (INO-741) / Rocket Pharma  (0 Trials)

anti-folate receptor beta antibodies (IP 1001E) / Roche  (0 Trials)

anti-FR alpha peptide vaccine / GemVax & KAEL  (0 Trials)

anti-GD2 CAR-T cell therapy / Bellicum, National Cancer Institute  (0 Trials)

anti-HER2 antibody conjugated with pegylated liposomal doxorubicin (MM-302) / Merrimack  (1 Trials)

anti-HGF (hu)mAb 2.12.1 / Amgen  (0 Trials)

anti-HGF (hu)mAb 2.4.4 / Amgen  (0 Trials)

Anti-HMBG1 Mab / Chiesi  (0 Trials)

anti-IFN α receptor mAb / Roche  (0 Trials)

anti-IL-4RA SNA / Exicure  (0 Trials)

anti-IL1RAP / Larix Biosci  (0 Trials)

anti-IL23 / Perrigo Company, Archemix  (0 Trials)

anti-infective bacteriophage therapy (PP-1231) / Pherecydes Pharma  (0 Trials)

anti-infective bacteriophages (PP-2351) / Pherecydes Pharma  (0 Trials)

anti-infective therapeutics / AiCuris, Ligand  (0 Trials)

anti-integrin αvβ5 mAb / Biogen  (0 Trials)

anti-KRAS G12D mTCR PBL / Gilead  (0 Trials)

anti-LAG-3 mAb / North Coast Biologics  (0 Trials)

anti-LeY- scFv-CD28-ζ vector / Peter MacCallum Cancer Centre, BMS  (3 Trials)

anti-Mesothelin CAR NK Cells / Allife Medical Science and Technology  (1 Trials)

anti-mesothelin gene engineered lymphocytes / National Cancer Institute  (0 Trials)

anti-MICA/B antibody / BMS  (0 Trials)

anti-MUC1 CAR-pNK cells / PersonGen Biomedicine  (1 Trials)

anti-MUC1 CAR-T cells / PersonGen Biomedicine  (2 Trials)

anti-MUC1 CAR-T cells / Guangdong Pharmaceutical University, Guangzhou Anjie Biomedical Technology  (2 Trials)

anti-Notch1NRR antibody / Roche, Exelixis  (0 Trials)

anti-OX40 (CD134) / AstraZeneca  (0 Trials)

anti-PAR2 mAb / Sosei  (0 Trials)

anti-PD-1 antibody / Tikcro Technologies  (0 Trials)

anti-PD-1 antibody / Premier Biomedical  (0 Trials)

anti-PD-1 scFv/anti-CTLA4 scFv / Anaeropharma Science  (0 Trials)

anti-PD-1 vaccine / Immunovo  (0 Trials)

anti-PD-L1 antibody / Tikcro Technologies  (0 Trials)

anti-PD-L1 CSR T cells / Marino Biotech  (2 Trials)

anti-PD-L1 therapy / The Wistar Institute  (0 Trials)

anti-PD1 DARPin anticancer therapy / Molecular Partners  (0 Trials)

anti-PD1 monoclonal antibody / Chinook Therap  (0 Trials)

anti-pertussis toxin / Sanofi  (0 Trials)

anti-phosphatidylserine monoclonal antibodies / Avid Bioservices, Affitech  (0 Trials)

anti-proliferative therapeutic / DiscoveryBioMed  (0 Trials)

anti-PSMA CAR NK cells / Allife Medical Science and Technology  (1 Trials)

Anti-PSMA Designer T Cells / Roger Williams Medical Center  (0 Trials)

anti-PTH1R / Xoma  (0 Trials)

anti-rabies serum / Serum Institute of India  (0 Trials)

anti-RSV Ab / AIM Therap  (0 Trials)

anti-SARS-CoV-2 convalescent plasma / Mayo Clinic  (2 Trials)

anti-SARS-CoV-2 convalescent plasma / University of Chicago  (0 Trials)

anti-SARS-CoV-2 convalescent plasma / OrthoSera  (1 Trials)

anti-SARS-CoV-2 convalescent plasma / Medical College of Wisconsin  (1 Trials)

anti-SARS-CoV-2 convalescent plasma / Miller School of Medicine, UT Health Science Center, Albert Einstein College of Medicine, NYU Langone Health, Montefiore Health  (0 Trials)

anti-SARS-CoV-2 convalescent plasma / Max Healthcare  (0 Trials)

Anti-SARS-CoV-2 equine immunoglobulin formulation / University of Costa Rica  (1 Trials)

anti-SARS-CoV-2 inactivated convalescent plasma / Shanghai Public Health Clinical Center  (1 Trials)

anti-SARS-CoV-2 virus inactivated plasma  / Wuhan University  (1 Trials)

anti-SARS-CoV-2-specific dMAb / Inovio, The Wistar Institute, AstraZeneca, Indiana University, University of Pennsylvania  (0 Trials)

anti-shiga toxin hyperimmune equine immunoglobulin F(ab')2 fragment (INM004) / Inmunova  (0 Trials)

anti-SIRPα D-peptide therapeutic / Navigen  (0 Trials)

Anti-SLAMF7 CAR T cells / National Cancer Center  (0 Trials)

Anti-tau vaccine / Vaxxinity  (0 Trials)

anti-TCR monoclonal antibodies / Medigene, German Research Center for Environmental Health, Max Delbrück Centre for Molecular Medicine  (0 Trials)

Anti-thymocyte globulin / Grifols  (0 Trials)

anti-TIGIT antibody / Tikcro Technologies  (0 Trials)

anti-TIM-3 mAb / North Coast Biologics  (0 Trials)

anti-TIM3 antibodies / Merus  (0 Trials)

Anti-TIM3 mAbs / Trellis Biosci  (0 Trials)

anti-TNF/IL-17A FynomAb (COVA322) / J&J  (0 Trials)

anti-trkC mAb / NETRIS Pharma  (0 Trials)

anti-VEGF therapy / 4D Molecular Therap  (0 Trials)

Anti-viroporin therapeutics / Biotron  (0 Trials)

Anti-Zika IgG / Kamada  (0 Trials)

antiangiogenic therapeutic / Exonate  (0 Trials)

antibody recruiting molecule NK cell combination therapy / Green Cross Cell, Portage  (0 Trials)

antibody recruiting molecule taniraleucel combination therapy / Celularity, Portage  (0 Trials)

antibody rich plasma / Ain Shams University  (1 Trials)

antibody therapies / Hanwha Chem  (0 Trials)

antibody-based NK cell stimulant cancer therapeutics / Affimed, Roche  (0 Trials)

anticancer gene therapy / Takara  (0 Trials)

AntiCovir (interferon a2b inhalation) / BetterLife Pharma  (1 Trials)

antidiabetic/metabolic therapy program / Lundbeck  (0 Trials)

Antiferon (interferon alpha kinoid) / Neovacs  (0 Trials)

antigen processing-independent epitopes / Apitope  (0 Trials)

antihypertensives (NicOx-3) / Nicox  (0 Trials)

Antilfa (odulimomab) / Sanofi  (0 Trials)

antimycon (AMINI77) / Cytocom  (0 Trials)

antisense LNA (EZN-3042) / Enzon  (0 Trials)

antisense LNA (EZN-4176) / Enzon  (0 Trials)

antisense oligonucleotide based coronovirus therapy / Sun Yat-sen University, Secarna  (0 Trials)

antisense oligonucleotide therapy / Sarepta Therap  (0 Trials)

antisense oligonucleotides for epilepsy / Q-State Biosci  (0 Trials)

antithrombotic / Shifa Biomedical Corp  (0 Trials)

antiviral therapeutics / Cyclica, Chinese Academy of Medical Sciences  (0 Trials)

ANV-201 / Anvil Bio  (0 Trials)

ANV419 / Anaveon  (1 Trials)

ANVS405 / Annovis Bio  (0 Trials)

ANX-042 / Anexon  (1 Trials)

ANX005 / Annexon Biosci  (6 Trials)

ANX007 / Annexon Biosci  (1 Trials)

ANX009 / Annexon Biosci  (0 Trials)

ANXV / Annexin  (1 Trials)

Anyara (naptumomab estafenatox) / NeoTX  (2 Trials)

AO-176 / Arch Oncology  (2 Trials)

AOC 1001 / Avidity Biosci  (1 Trials)

AOC-DMD exon 44 skipping program / Eli Lilly  (0 Trials)

AOC-DMD exon 45 skipping program / Eli Lilly  (0 Trials)

AOC-DMD exon 51 skipping program / Eli Lilly, Avidity Biosci  (0 Trials)

AOC-Pompe Disease / Eli Lilly, Avidity Biosci  (0 Trials)

AOVA-10/20 (atorvastatin) / Aamorb Pharma  (0 Trials)

AP 1102 / Action Pharma  (0 Trials)

AP-002 / BetterLife Pharma  (1 Trials)

AP-101 / AL-S Pharma  (2 Trials)

AP-2600 / Arissa  (0 Trials)

AP-472 / Appello Pharma  (0 Trials)

AP-768 / Boehringer Ingelheim  (0 Trials)

AP-L1898 / Suzhou Junjing Biomed  (1 Trials)

AP-PA02 / Armata  (1 Trials)

AP-SA01 / Armata  (1 Trials)

AP032 (darbepoetin alfa biosimilar) / Aprogen, Nichi-Iko, Sanofi  (0 Trials)

AP052 (rituximab biosimilar) / Aprogen, Sanofi, Nichi-Iko  (0 Trials)

AP062 (trastuzumab biosimilar) / Aprogen, Nichi-Iko, Sanofi  (0 Trials)

AP1030 / Action  (0 Trials)

AP105 / AP Biosciences  (0 Trials)

AP116 / AP Biosciences  (0 Trials)

AP1189 / SynAct Pharma  (2 Trials)

AP30663 / Acesion  (1 Trials)

AP405 / Action Pharma  (0 Trials)

apabetalone (RVX 208) / Resverlogix  (5 Trials)

apadamtase alfa (TAK-755) / Takeda, Meiji Seika  (4 Trials)

Apadaz (benzhydrocodone/acetaminophen) / KemPharm, KVK Tech, Sure Med Compliance  (0 Trials)

apararenone (MT-3995) / Mitsubishi Tanabe  (0 Trials)

Apatone B (ascorbic acid/menadione) / Summa Health, IC-MedTech  (0 Trials)

apatorsen (OGX-427) / Achieve Life Sciences  (3 Trials)

Apaza (mesalamine/4-aminophenylacetic acid) / 9 Meters Biopharma  (0 Trials)

APB-101 / Apic Bio  (0 Trials)

APB-102 / Apic Bio  (0 Trials)

APC-100 / Adamis  (1 Trials)

APCEDEN-CR (autologous dendritic cell immunotherapy) / APAC Biotech  (0 Trials)

APCEDEN-O (autologous dendritic cell immunotherapy) / APAC Biotech  (0 Trials)

APCEDEN-P (autologous dendritic cell immunotherapy) / APAC Biotech  (0 Trials)

Apceth regeneration and disease modulation program / Minaris Regenerative Medicine  (0 Trials)

apceth-301 / Minaris Regenerative Medicine  (0 Trials)

APD-209 / Adenovir  (0 Trials)

APD418 / Arena  (0 Trials)

APD597 / Arena  (0 Trials)

Apeaz (camphor +menthol +methyl salicylate) / Innovus  (0 Trials)

APG 101.10 / Allostera  (0 Trials)

APG 201 / Apogenix, German Cancer Research Center  (0 Trials)

APG-1387 / Ascentage Pharma  (5 Trials)

APG-2449 / Ascentage Pharma  (1 Trials)

APG-265 / Ascentage Pharma  (0 Trials)